This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Analyst Reports for Chevron, Novartis & Qualcomm
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Chevron (CVX), Novartis (NVS) and Qualcomm (QCOM)
The Zacks Analyst Blog Highlights: Oracle, Netflix, Danaher, State Street and Rogers Communications
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Oracle, Netflix, Danaher, State Street and Rogers Communications
Top Research Reports for Oracle, Netflix & Danaher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Oracle (ORCL), Netflix (NFLX) and Danaher (DHR).
State Street (STT) Q3 Earnings & Revenues Miss, Expenses Up
by Zacks Equity Research
Rise in interest rates, higher fee income and growth in assets under management support State Street's (STT) Q3 earnings while an increase in operating expenses is a dampener.
Earnings Season At Full Throttle
by Zacks Equity Research
Earnings Season At Full Throttle
Q3 Earnings Season Rolls On: Some Hits, Some Whiffs
by Mark Vickery
New earnings results from P&G, Honeywell, V.F. Corp. and more this morning are decidedly a mixed bag.
State Street (STT) Misses on Q3 Earnings & Revenue Estimates
by Zacks Equity Research
Higher operating expenses hurt State Street's (STT) Q3 earnings.
Are Q3 Earnings Results Really Good?
by Sheraz Mian
The banks gave us a good start to the Q3 earnings season, with the market appreciating (and rewarding) the money-center banks and brokers for their results.
What's in the Offing for State Street's (STT) Q3 Earnings?
by Zacks Equity Research
While muted fee revenue growth is likely to hurt State Street's (STT) top line in Q3, higher rates might drive net interest income growth, thereby lending some support.
State Street (STT) Q3 Earnings Preview: What to Watch Ahead of the Release
by Zacks Equity Research
State Street (STT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Subdued Trading Business to Hurt Goldman (GS) Q3 Earnings?
by Zacks Equity Research
Goldman Sachs (GS) to report third-quarter earnings on Oct 16, before the market opens.
Will Comerica (CMA) Keep Earnings Beat Streak Alive in Q3?
by Zacks Equity Research
Comerica's (CMA) Q3 earnings are expected to benefit from higher revenues, controlled expenses and improved credit quality despite seasonality offsetting some of the positives.
5 Major Bank Stocks Poised to Surpass Q3 Earnings Estimates
by Zacks Equity Research
Major banks are expected to witness dismal performance in capital markets-related businesses in Q3. But decent loan growth, solid asset quality and rise in interest rates will provide some support.
Will Industry Seasonality Dampen Citigroup's (C) Q3 Earnings?
by Zacks Equity Research
Citigroup's (C) consumer banking business expected to put up an impressive performance in the Jul-Sep quarter. However, fixed income and equity trading revenues will likely be flat to slightly higher.
Will Mortgage Weakness Hurt Wells Fargo's (WFC) Q3 Earnings?
by Zacks Equity Research
Wells Fargo's (WFC) Q3 results are likely to witness pressure on revenues majorly due to lower fee income. Also, loan growth is likely to be muted.
Will Fee Income Support PNC Financial (PNC) in Q3 Earnings?
by Zacks Equity Research
PNC Financial (PNC) Q3 earnings might reflect benefit from fee income growth, majorly in asset management and consumer service segments.
State Street Closes Charles River Development Buyout Deal
by Zacks Equity Research
State Street's (STT) acquisition of Charles River Development will support the development of an internationally inter-operable platform which will back its investment process.
MetLife Focuses on Streamlining Business to Boost Growth
by Zacks Equity Research
Sale of low-growth and non-core businesses, and focus on growing profitable ones position MetLife (MET) for further growth.
The Zacks Analyst Blog Highlights: IBM, Texas Instruments, Glaxo, Simon Property Group and State Street
by Zacks Equity Research
The Zacks Analyst Blog Highlights: IBM, Texas Instruments, Glaxo, Simon Property Group and State Street
Top Stock Reports for IBM, Texas Instruments & Glaxo
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including IBM (IBM), Texas Instruments (TXN) and Glaxo (GSK).
MetLife Ties Up With State Street to Buoy Investment Business
by Zacks Equity Research
MetLife (MET) partners with State Street to grow its commercial lending business.
Earnings Data Deluge
by Zacks Equity Research
Earnings Data Deluge
Q2 Earnings Point Markets Forward: MSFT, GE, VFC & More
by Mark Vickery
Q2 results continue to heat up at the end of this first full week of earnings season, with GE, State Street, Schlumberger and more reporting results before today's opening bell.
State Street (STT) Beats on Q2 Earnings, to Acquire CRD
by Zacks Equity Research
State Street's (STT) Q2 earnings reflect strong fundamentals. The acquisition of Charles River Development will be accretive to earnings in 2020.
State Street (STT) Beats on Q2 Earnings, Revenue Rise Y/Y
by Zacks Equity Research
State Street's (STT) Q2 earnings reflect revenue growth. The announcement of deal to acquire Charles River Development is other positive for the company.